10x Genomics, Inc.: total liabilities
Total liabilities for 10x Genomics, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All 10x Genomics, Inc. financial histories
What this measure means
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
Exact concept: us-gaap:Liabilities. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2018-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 245,039,000 | USD | 2026-02-13 | 10-K · 0001628280-26-007822 |
| At date | 2024-12-31 | 208,502,000 | USD | 2026-02-13 | 10-K · 0001628280-26-007822 |
| At date | 2023-12-31 | 224,100,000 | USD | 2025-02-13 | 10-K · 0001770787-25-000013 |
| At date | 2022-12-31 | 223,237,000 | USD | 2024-02-15 | 10-K · 0001770787-24-000017 |
| At date | 2021-12-31 | 201,258,000 | USD | 2023-02-16 | 10-K · 0001770787-23-000012 |
| At date | 2020-12-31 | 190,269,000 | USD | 2022-02-18 | 10-K · 0001770787-22-000015 |
| At date | 2020-01-01 | 78,139,000 | USD | 2021-02-26 | 10-K · 0001770787-21-000009 |
| At date | 2019-12-31 | 185,840,000 | USD | 2021-02-26 | 10-K · 0001770787-21-000009 |
| At date | 2018-12-31 | 101,053,000 | USD | 2020-02-27 | 10-K · 0001193125-20-052640 |
Related financial histories
- 10x Genomics, Inc.: total assets
- 10x Genomics, Inc.: stockholders equity
- 10x Genomics, Inc.: cash and cash equivalents
- 10x Genomics, Inc.: net income or loss
- 10x Genomics, Inc.: operating cash flow
- 10x Genomics, Inc.: capital expenditure payments
- 10x Genomics, Inc.: revenue
- 10x Genomics, Inc.: contract revenue excluding tax
- 10x Genomics, Inc.: financing cash flow
- 10x Genomics, Inc.: investing cash flow
- 10x Genomics, Inc.: retained earnings or deficit
- 10x Genomics, Inc.: basic weighted-average shares
- 10x Genomics, Inc.: diluted weighted-average shares
- 10x Genomics, Inc.: basic earnings per share
- 10x Genomics, Inc.: diluted earnings per share
- 10x Genomics, Inc.: income tax expense or benefit
- 10x Genomics, Inc.: net property, plant and equipment
- 10x Genomics, Inc.: share-based compensation expense
- 10x Genomics, Inc.: operating income or loss
- 10x Genomics, Inc.: current assets
- 10x Genomics, Inc.: interest expense
- 10x Genomics, Inc.: current liabilities
- 10x Genomics, Inc.: current accounts payable
- 10x Genomics, Inc.: goodwill carrying amount
- 10x Genomics, Inc.: net finite-lived intangible assets
- 10x Genomics, Inc.: net current accounts receivable
- 10x Genomics, Inc.: operating expenses
- 10x Genomics, Inc.: net inventory
- 10x Genomics, Inc.: gross profit
- 10x Genomics, Inc.: cost of revenue
- 10x Genomics, Inc.: selling, general and administrative expense
Inspect the source
- Entity
- 10x Genomics, Inc. / CIK 0001770787
- Captured
- 2026-09-21T17:30:11.797Z
- SEC response SHA-256
2f61e04b1626c1c2d1f4d43810aa79e5651a901f79993ed49ad3870c17a80e07
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001770787.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))